A subgroup analysis of JUMP, a phase IIIb, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis in a Brazilian cohort
Autor: | Tavares, Renato, Souza, Carmino Antonio De, Paley, Carole, Bouard, Catherine, Tiwari, Ranjan, Pasquini, Ricardo |
---|---|
Zdroj: | In Hematology, Transfusion and Cell Therapy January-March 2020 42(1):46-53 |
Databáze: | ScienceDirect |
Externí odkaz: |